MediBeacon
Germany - MannheimBiotechnology
Focus: MediBeacon is a German biotech specialist in proprietary fluorescent tracer agents and transdermal detection systems, focused on nephrology and immunology applications. The company operates at mid-cap scale (201-500 employees) with a pipeline-driven model.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Employees
201-500
Open Jobs
1
Should You Work at MediBeacon?
AI assessmentMediBeacon is a specialized, mission-driven biotech with novel technology in a focused disease area, but limited hiring and opacity around finances make it a higher-risk career move unless you prioritize deep technical expertise over growth or stability.
Why Work Here
- Leading position in fluorescent tracer technology with multiple Phase 3 programs in kidney disease, a high-unmet-need therapeutic area
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growing
Growth
Lead fluorescent tracer platform being evaluated across multiple renal indications in Phase 1 trials.
Help build intelligence for MediBeacon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.